Hypertrophic Cardiomyopathy (HCM): Innovative Options for Treatment

To learn more about the Hypertrophic Cardiomyopathy Center, please visit cle.clinic/3aYKgaP
Hypertrophic Cardiomyopathy (HCM) in the majority of cases causes restriction of blood flow in the outflow tract of the heart caused by systolic anterior motion (SAM) of the mitral valve. Dr. Steve Nissen talks with cardiologist Dr. Milind Desai and surgeon Dr. Nick Smedira, Directors of the Hypertrophic Cardiomyopathy Center about current treatment options, such as medications and surgical therapy, what we have learned from years of experience with HCM at Cleveland Clinic, and a new innovative medication that is being researched that may reduce the need for - or delay surgery.

[@republicanrule]

Just read up on the new drug they talk about in this video. Sounds very promising and fairly close to being FDA approved for general use.

[@sunving]

Thank you Doctors,

[@johnnynoirman]

I need this treatment.

[@mjohnson9946]

What about stem cells for treating HCM

[@waq4s]

Great video! I hate HCM, it almost killed me last month.

[@mohammadosama8464]

with you, brother.

[@ghotraaas146]

Brother what was your size of septum?

[@ghotraaas146]

@@mohammadosama8464 brother what is your size of septum?

[@theone1602n]

Same

[@joeb3949]

What does your treatment look like ? I plan on getting a referral to the CC very soon to pursue a septal myectomy.

[@TheReelSoupeKitchen]

Sign me up for the new study

[@Boncoh]

The drug got approved by the FDA. Hope you’re doing well! It is called mavacamten.

[@TheReelSoupeKitchen]

@@Boncoh I actually had heart surgery earlier this year to fix my issues